These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 33184193)

  • 1. Enhancing host cell infection by SARS-CoV-2.
    Kielian M
    Science; 2020 Nov; 370(6518):765-766. PubMed ID: 33184193
    [No Abstract]   [Full Text] [Related]  

  • 2. A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).
    Awais S; Shah SFH; Shah SGS
    Int J Surg; 2020 Nov; 83():28-29. PubMed ID: 32927142
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.
    Su YJ; Lai YC
    Travel Med Infect Dis; 2020; 36():101625. PubMed ID: 32184131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative overview of COVID-19, MERS and SARS: Review article.
    Liu J; Xie W; Wang Y; Xiong Y; Chen S; Han J; Wu Q
    Int J Surg; 2020 Sep; 81():1-8. PubMed ID: 32730205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on healthcare workers & SARS-CoV-2 infection.
    Barde P; Sarkate P; Gaikwad N
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):137-138. PubMed ID: 32773418
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on article on healthcare workers & SARS-CoV-2 infection.
    Kulkarni AP
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):141-142. PubMed ID: 32773422
    [No Abstract]   [Full Text] [Related]  

  • 7. Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19.
    Byard RW; Hunsaker J; Tsokos M
    Forensic Sci Med Pathol; 2020 Dec; 16(4):745. PubMed ID: 33104977
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 infection among healthcare workers in India: Limitations of the case-control investigation.
    Niranjan V; Kinnersley N
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):143-144. PubMed ID: 32773426
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary.
    Galvan V; Quarleri J
    Geroscience; 2020 Oct; 42(5):1221-1223. PubMed ID: 32737759
    [No Abstract]   [Full Text] [Related]  

  • 10. A global health perspective on SARS-CoV-2-hazards, disaster and hope.
    Meyer S; Papan C; Last K
    Wien Med Wochenschr; 2020 Oct; 170(13-14):357-358. PubMed ID: 32929620
    [No Abstract]   [Full Text] [Related]  

  • 11. Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2.
    Pitzer VE; Cohen T
    Lancet Infect Dis; 2020 Oct; 20(10):1103-1104. PubMed ID: 32562602
    [No Abstract]   [Full Text] [Related]  

  • 12. COVID-19 and SARS: Differences and similarities.
    Caldaria A; Conforti C; Di Meo N; Dianzani C; Jafferany M; Lotti T; Zalaudek I; Giuffrida R
    Dermatol Ther; 2020 Jul; 33(4):e13395. PubMed ID: 32277530
    [No Abstract]   [Full Text] [Related]  

  • 13. From severe acute respiratory syndrome-associated coronavirus to 2019 novel coronavirus outbreak: similarities in the early epidemics and prediction of future trends.
    Chen ZL; Zhang WJ; Lu Y; Guo C; Guo ZM; Liao CH; Zhang X; Zhang Y; Han XH; Li QL; Lu JH
    Chin Med J (Engl); 2020 May; 133(9):1112-1114. PubMed ID: 32118641
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges of SARS-CoV-2 and lessons learnt from SARS in Guangdong Province, China.
    Zhang J; Lin G; Zeng J; Lin J; Tian J; Li G
    J Clin Virol; 2020 May; 126():104341. PubMed ID: 32278300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations.
    Drago F; Ciccarese G; Rebora A; Muzic SI; Parodi A
    Br J Dermatol; 2020 Oct; 183(4):788. PubMed ID: 32533844
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of simulation-CT's as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic.
    Nevens D; Billiet C; Weytjens R; Joye I; Machiels M; Vermylen A; Chiari I; Bauwens W; Vermeulen P; Dirix L; Huget P; Verellen D; Dirix P; Meijnders P
    Radiother Oncol; 2020 Oct; 151():17-19. PubMed ID: 32679307
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens: Diagnostic and Infection Control Implications.
    Murphy K
    Chest; 2020 Nov; 158(5):1804-1805. PubMed ID: 33160519
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR: reflecting on experience from MERS-CoV.
    Al-Tawfiq JA; Memish ZA
    J Hosp Infect; 2020 Jun; 105(2):154-155. PubMed ID: 32147407
    [No Abstract]   [Full Text] [Related]  

  • 19. From SARS to COVID-19: the Singapore journey.
    Lin RJ; Lee TH; Lye DC
    Med J Aust; 2020 Jun; 212(11):497-502.e1. PubMed ID: 32474940
    [No Abstract]   [Full Text] [Related]  

  • 20. High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
    van Dam PA; Huizing M; Papadimitriou K; Prenen H; Peeters M
    Eur J Cancer; 2020 Oct; 138():225-227. PubMed ID: 32927375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.